IV Solutions
0.9% Sodium Chloride Injection, USP, in Fleboflex Luer container
Partners in secure solutions
Delivering an innovative, safe, and convenient IV solution
Fleboflex® Luer is an innovative container that combines safety and convenience when preparing and administering IV drugs
- Made of polypropylene: free of PVC, plasticizers, adhesives, and latex
- With a needle-free system that avoids the risk of accidental punctures
- Comes partially filled: large additive volume
Prevention of accidental needle stick injuries
No dripping when connecting and disconnecting the syringe or vial adaptor
Avoids potential spike drops
No potential risk of microbiological contamination in the manipulation
Fleboflex® Luer means convenience
Large additive volume
Smooth and quick addition and removal of medication that prevents RSI (repetitive strain injury) syndrome
High flow rate of the solution
High resistance to pressure cuffs, responding satisfactorily to 400 mmHg pressure for 72 hours
Volume details
Fleboflex® Luer
Max. additive volume in mL up to a pressure of 50 mL bar
- 50/100 mL
-
136
- 100/250 mL
-
289
- 250/500 mL
-
422
- 500/1000 mL
-
639
Maximum removable volume (mL)
- 50/100 mL
-
187
- 100/250 mL
-
394
- 250/500 mL
-
677
- 500/1000 mL
-
1139
Residual volume (mL)
- 50/100 mL
-
0.3-1.8
- 100/250 mL
-
0.3-1.5
- 250/500 mL
-
0.2-1.9
- 500/1000 mL
-
0.2-2.6
Air volume (mL)
- 50/100 mL
-
4-5
- 100/250 mL
-
5-20
- 250/500 mL
-
12-30
- 500/1000 mL
-
15-30
| Fleboflex® Luer | 50/100 mL | 100/250 mL | 250/500 mL | 500/1000 mL |
|---|---|---|---|---|
|
Max. additive volume in mL up to a pressure of 50 mL bar |
136 |
289 |
422 |
639 |
|
Maximum removable volume (mL) |
187 |
394 |
677 |
1139 |
|
Residual volume (mL) |
0.3-1.8 |
0.3-1.5 |
0.2-1.9 |
0.2-2.6 |
|
Air volume (mL) |
4-5 |
5-20 |
12-30 |
15-30 |
Drug
Bleomycin sulfate
- Size
-
0.15 U/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Carboplatin
- Size
-
0.5 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Cisplatin
- Size
-
0.5 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Cytarabine
- Size
-
13 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
1 day
Dacarbazine*‡§
- Size
-
3.4 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Docetaxel
- Size
-
0.3 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Etoposide
- Size
-
0.3 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Epirubicin
- Size
-
2 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Fludarabine
- Size
-
6 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Gemcitabine
- Size
-
4 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Idarubicin
- Size
-
1 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Ifosfamide
- Size
-
1 mg/mL in SC
- 25 °C (77 °F)†
-
7 days
Irinotecan
- Size
-
2.8 mg/mL in SC
- 25 °C (77 °F)†
-
7 days
Methotrexate
- Size
-
1 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Mitoxantrone
- Size
-
0.2 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Oxaliplatin
- Size
-
0.6 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Paclitaxel
- Size
-
0.3 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Vinblastine
- Size
-
0.2 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Vincristine
- Size
-
0.04 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
Vinorelbine
- Size
-
1 mg/mL in 0.9% SC
- 25 °C (77 °F)†
-
7 days
| Drug | Size | 25 °C (77 °F)† |
|---|---|---|
|
Bleomycin sulfate |
0.15 U/mL in 0.9% SC |
7 days |
|
Carboplatin |
0.5 mg/mL in 0.9% SC |
7 days |
|
Cisplatin |
0.5 mg/mL in 0.9% SC |
7 days |
|
Cytarabine |
13 mg/mL in 0.9% SC |
1 day |
|
Dacarbazine*ठ|
3.4 mg/mL in 0.9% SC |
7 days |
|
Docetaxel |
0.3 mg/mL in 0.9% SC |
7 days |
|
Etoposide |
0.3 mg/mL in 0.9% SC |
7 days |
|
Epirubicin |
2 mg/mL in 0.9% SC |
7 days |
|
Fludarabine |
6 mg/mL in 0.9% SC |
7 days |
|
Gemcitabine |
4 mg/mL in 0.9% SC |
7 days |
|
Idarubicin |
1 mg/mL in 0.9% SC |
7 days |
|
Ifosfamide |
1 mg/mL in SC |
7 days |
|
Irinotecan |
2.8 mg/mL in SC |
7 days |
|
Methotrexate |
1 mg/mL in 0.9% SC |
7 days |
|
Mitoxantrone |
0.2 mg/mL in 0.9% SC |
7 days |
|
Oxaliplatin |
0.6 mg/mL in 0.9% SC |
7 days |
|
Paclitaxel |
0.3 mg/mL in 0.9% SC |
7 days |
|
Vinblastine |
0.2 mg/mL in 0.9% SC |
7 days |
|
Vincristine |
0.04 mg/mL in 0.9% SC |
7 days |
|
Vinorelbine |
1 mg/mL in 0.9% SC |
7 days |
Bag features
1
Designed for safe and easy handling
Integrated eyelet support for easy and safe handling of the container during the infusion.
2
Product information
- Inclusion of the National Drug Code
- Inclusion of lot and expiration date
- Sequential number
Highly compatible material
The solution is only in contact with polypropylene. Both the multilayer film and the inner membranes of the medication and outlet ports contain only polypropylene.
Polypropylene can be sterilized at a higher temperature because it resists heat better than other olefins.
3
High sealing resistance
High resistance to pressure cuffs.
4
Injection/extraction port
Luer-lock valve for automatic locking that allows easy, quick, and safe access to the interior of the bag through the connection of a needle-free syringe or a male vial adaptor.
5
Infusion port
Hermetic twist-off made of polypropylene for the connection of the infusion equipment. It maintains sterility until opened.
Description
0.9% Sodium Chloride Injection, USP 50/100 mL
- NDC Number
-
76297-001-51
- Case weight Kg
-
9
- Bags/ box
-
90
- Bags/ pallet
-
2880
- Bags/ container*
-
132,480
0.9% Sodium Chloride Injection, USP 100/250 mL
- NDC Number
-
76297-001-61
- Case weight Kg
-
12
- Bags/ box
-
50
- Bags/ pallet
-
1600
- Bags/ container*
-
73,600
0.9% Sodium Chloride Injection, USP 250/500 mL
- NDC Number
-
76297-001-71
- Case weight Kg
-
15
- Bags/ box
-
32
- Bags/ pallet
-
1024
- Bags/ container*
-
47,104
0.9% Sodium Chloride Injection, USP 500/1000 mL
- NDC Number
-
76297-001-81
- Case weight Kg
-
19
- Bags/ box
-
24
- Bags/ pallet
-
768
- Bags/ container*
-
35,328
| Description | NDC Number | Case weight Kg | Bags/ box | Bags/ pallet | Bags/ container* |
|---|---|---|---|---|---|
|
0.9% Sodium Chloride Injection, USP 50/100 mL |
76297-001-51 |
9 |
90 |
2880 |
132,480 |
|
0.9% Sodium Chloride Injection, USP 100/250 mL |
76297-001-61 |
12 |
50 |
1600 |
73,600 |
|
0.9% Sodium Chloride Injection, USP 250/500 mL |
76297-001-71 |
15 |
32 |
1024 |
47,104 |
|
0.9% Sodium Chloride Injection, USP 500/1000 mL |
76297-001-81 |
19 |
24 |
768 |
35,328 |
Guidelines for use of 0.9% Sodium Chloride solution in Fleboflex® Luer container
Overwrap removal
- The overwrap is designed to be opened by pulling apart the 2 sheets of the overwrap.
- The recommended method to remove the overwrap is to peel off one sheet by the corner while holding the other sheet at one end to carefully remove the solution container.
The overwrap should not be removed until product is to be used.
Container inspection
- Visually inspect the container for particulate matter and discoloration
- Check for minute leaks by squeezing the inner container firmly. If leaks are found, discard the solution as sterility may be impaired
- If the ports are damaged, detached, or not present, discard the container as solution path sterility may be impaired
- Do not administer unless the solution is clear and the seal is intact
Adding medications and solution removal with a needle-free syringe
- Connect a syringe to the luer valve.
- Secure the connection with a small rotational movement.
- Add or remove solution.
The compatibility of the additives with Sodium Chloride 0.9% must be checked before adding a medication.
Reconstitution of vials with a vial adaptor
- Remove the protective foil from the blister containing the vial adaptor. Do not remove the adaptor from the blister.
- Without removing the blister, connect the vial adaptor to the vial by pressing vertically on the surface until the adaptor is fixed and the awl has penetrated the surface of the vial.
- Remove the blister.
- The vial with the vial adaptor is ready to reconstitute once connected to the luer valve of the bag.
Fleboflex® Luer Brochure
Fleboflex® Luer Product Overview
Learn more about the Fleboflex® Luer product
Fleboflex® Luer with CSTD video
Learn more about 0.9% Sodium Chloride Injection, USP, in Fleboflex® Luer plastic container when using CSTDs
Get to know Fleboflex® Luer
Learn more about Fleboflex® Luer in the following e-learning course
Do you have any questions or concerns?
Contact a Grifols representative for more information